CULTURE

The Cure set to front Terravibe Festival in September with trans-pop act Cranes

From their very first appearance in the music business, it was obvious that the Cure would turn out to be special, a band that would be very hard to imitate. They may have changed a lot with the passing of time, mostly because of their singer, Robert Smith, who started out as a melancholy teenager with a gifted voice and turned into a bit of a caricature of himself (the only thing that reminds us of the good old days is the heavy makeup), yet they remain to this day one of the most important chapters of the contemporary rock scene. They have a unique sound and during their 30-year career have produced masterpiece albums including «Seventeen Seconds,» «Faith» and «Pornography.» On September 1, Greek audiences will have the opportunity to see the Cure live at the Terravibe stage in Malakassa (the same venue where the Rockwave Festival is held); the group will be the main stars of the Terravibe Festival, with which Didi Music Big Star Promotion calls on the public to end the summer. Festival participants The Cure will be accompanied by Cranes, a trans-pop group which combines sensual vocals and melodies with strong guitars. Founded in Portsmouth in 1988, they became more widely known when Robert Smith invited them to open the Cure’s concerts during the group’s 1992 tour. The festival will also feature performances by Greek artists, namely singer and musician Alkinoos Ioannidis as well as Film, a four-member English-speaking act which plays alternative pop-rock music. A few days later, on September 10, California-based act Korn will play at the same venue. The group, which blends metal with hip-hop and other beats, will also perform at Thessaloniki’s Gis Theater on September 11. For the Cure: Tickets can be purchased at Athens’s Ticket House, situated at 42 Panepistimiou, tel 210.360.8366, and at Thessaloniki’s Ticket House, 20 Ethnikis Amynis & Tsimiski, tel 2310.253.630. Tickets cost 40 euros.

Subscribe to our Newsletters

Enter your information below to receive our weekly newsletters with the latest insights, opinion pieces and current events straight to your inbox.

By signing up you are agreeing to our Terms of Service and Privacy Policy.